Back
InMed Pharmaceuticals Stock Price Chart
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
41
INM
InMed Pharmaceuticals
Last Price:
$3.02
Seasonality Move:
-20.51%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.-
The current trend is relatively stagnant and INM is experiencing slight selling pressure.
InMed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.83 | Buy |
| 20-day SMA: | 2.78 | Buy |
| 50-day SMA: | 2.69 | Buy |
| 200-day SMA: | 4.06 | Sell |
| 8-day EMA: | 2.93 | Buy |
| 20-day EMA: | 2.84 | Buy |
| 50-day EMA: | 2.84 | Buy |
| 200-day EMA: | 4.6 | Sell |
InMed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 59.59 | Buy |
| Chaikin Money Flow: | -398536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 3.14) | Buy |
| Bollinger Bands (100): | (2.39 - 3.61) | Buy |
InMed Pharmaceuticals Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for InMed Pharmaceuticals Stock
Is InMed Pharmaceuticals Stock a Buy?
-
InMed Pharmaceuticals share price is 3.32 while INM 8-day simple moving average is 2.83, which is a Buy signal.
-
The stock price of INM is 3.32 while InMed Pharmaceuticals 20-day SMA is 2.78, which makes it a Buy.
-
InMed Pharmaceuticals 50-day simple moving average is 2.69 while INM share price is 3.32, making it a Buy technically.
-
INM stock price is 3.32 and InMed Pharmaceuticals 200-day simple moving average is 4.06, creating a Sell signal.
INM Technical Analysis vs Fundamental Analysis
Sell
41
InMed Pharmaceuticals (INM)
is a Sell
Is InMed Pharmaceuticals a Buy or a Sell?
-
InMed Pharmaceuticals stock is rated a SellThe current InMed Pharmaceuticals [INM] share price is $3.32. The Score for INM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
InMed Pharmaceuticals Stock Info
Market Cap:
3.6M
Price in USD:
3.32
Share Volume:
1.2M
InMed Pharmaceuticals 52-Week Range
52-Week High:
15.70
52-Week Low:
1.72
Sell
41
InMed Pharmaceuticals (INM)
is a Sell
InMed Pharmaceuticals Share Price Forecast
-
What is the InMed Pharmaceuticals stock price today?The InMed Pharmaceuticals stock price is 3.32 USD today.
-
Will INM stock go up or go down?InMed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is InMed Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, InMed Pharmaceuticals is overvalued.
Is InMed Pharmaceuticals Stock a Buy?
-
InMed Pharmaceuticals share price is 3.32 while INM 8-day exponential moving average is 2.93, which is a Buy signal.
-
The stock price of INM is 3.32 while InMed Pharmaceuticals 20-day EMA is 2.84, which makes it a Buy.
-
InMed Pharmaceuticals 50-day exponential moving average is 2.84 while INM share price is 3.32, making it a Buy technically.
-
INM stock price is 3.32 and InMed Pharmaceuticals 200-day simple moving average is 4.60, creating a Sell signal.
Technical Analysis of InMed Pharmaceuticals
Should I short InMed Pharmaceuticals stock?
-
INM Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting InMed Pharmaceuticals is a Buy
-
InMed Pharmaceuticals Relative Strength Index (RSI) is 59.59, which suggest InMed Pharmaceuticals is overbought
-
The Bollinger Bands (25) for InMed Pharmaceuticals is (2.52 - 3.14), which suggest InMed Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for InMed Pharmaceuticals is (2.39 - 3.61), which suggest InMed Pharmaceuticals is a Buy
* InMed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.